Nizams Institute of Medical Sciences

Hyderabad, Andhra Pradesh 500082

3 studies enrolling now · 9 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Generalized Myasthenia Gravis, Immunoglobulin A Nephropathy (IgAN), Inflammation, Migraine, Non-small-cell Lung Cancer, Obesity, Primary Membranous Nephropathy, Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — Recruiting now
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Completed
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer — Completed
• First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer — Stopped early